RxDoctor Payments Data

Emma Nordstrom, MD

Family Medicine · Lebanon, INNPI 1003136011

Payments from drug & device makers

$11,732in general payments, 2019–2025

Across 771 payments — averaging $15.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$1K
  • Lilly USA, LLC$953
  • Novo Nordisk$873
  • AstraZeneca$847
  • Johnson & Johnson$771
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$11,65499%
  • Education$380%
  • Other$400%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)145$1,963
Amgen75$1,176
Lilly USA, LLC73$953
Novo Nordisk67$873
AstraZeneca45$847
Johnson & Johnson49$771
GSK37$589
Pfizer43$519
Bayer23$453
Merck26$326
Sanofi-aventis U.S. LLC17$275
Boehringer Ingelheim14$229
Takeda Pharmaceuticals U.S.A., Inc.15$203
Dexcom, Inc.11$203
Novartis12$174
Abbott7$162
Nestle Healthcare Nutrition Inc.8$152
Otsuka America Pharmaceutical, Inc.8$134
Exact Sciences7$133
Biohaven Pharmaceuticals, Inc.7$108
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC7$104
Amarin Pharma, Inc.5$85
Phathom Pharmaceuticals, Inc.4$84
Shield Therapeutics Inc2$79
Astellas Pharma US Inc4$79
Mylan Specialty L.p.4$72
Medtronic4$69
Teva Pharmaceuticals USA, Inc.5$65
Sanofi Pasteur Inc.3$56
Sumitomo Pharma America, Inc.3$53
Biohaven Pharmaceutical Holding Company Ltd.3$47
Aimmune Therapeutics, Inc.2$46
Harmony Biosciences LLC2$46
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$41
Eisai Inc.2$39
Noven Therapeutics, LLC2$36
Ironshore Pharmaceuticals Inc.2$31
Si-bone, Inc.1$31
Daiichi Sankyo Inc.2$30
Edwards Lifesciences1$30
Supernus Pharmaceuticals, Inc.2$25
Ultragenyx Pharmaceutical Inc.1$25
Currax Pharmaceuticals LLC2$23
Grifols USA, LLC1$23
Argenx US, Inc.1$22
Jazz Pharmaceuticals Inc.1$20
Idorsia Pharmaceuticals US Inc1$20
Azurity Pharmaceuticals, Inc.1$20
Ironwood Pharmaceuticals, Inc1$19
Ardelyx, Inc.1$19
Collegium Pharmaceutical, Inc.1$18
Xeris Pharmaceuticals, Inc.1$18
Upsher-smith Laboratories LLC1$18
Shire North American Group Inc1$16
Halozyme Inc1$15
Paratek Pharmaceuticals, Inc.1$15
Lundbeck LLC1$13
Tris Pharma Inc1$12
Assertio Therapeutics, Inc.1$12
Radius Health, Inc.1$12

How this compares

$11,732 in reported general payments places this provider in the 95th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$173,710
Medicare patients
234
Services billed
3,160

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide202$282,397
JardianceEmpagliflozin157$171,011
OzempicSemaglutide90$123,240
EliquisApixaban111$105,846
Trelegy ElliptaFluticasone/Umeclidin/Vilanter76$83,073
TrulicityDulaglutide22$39,722
JanuviaSitagliptin Phosphate29$30,701
XareltoRivaroxaban25$26,351
Breo ElliptaFluticasone/Vilanterol48$24,912
MyrbetriqMirabegron42$23,084
Breztri AerosphereBudesonide/Glycopyr/Formoterol25$22,787
TradjentaLinagliptin30$22,328
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr31$19,848
Repatha SureclickEvolocumab18$19,082
TrintellixVortioxetine Hydrobromide23$17,561

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$953$322,119224 claims
Boehringer IngelheimJardiance, Tradjenta$229$193,339187 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$589$127,833155 claims
Novo NordiskOzempic$873$123,24090 claims
PfizerEliquis$519$105,846111 claims
MerckJanuvia$326$30,70129 claims
Johnson & JohnsonXarelto$771$26,35125 claims
AstraZenecaBreztri Aerosphere, Symbicort$847$26,21536 claims
Astellas Pharma US IncMyrbetriq$79$23,08442 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$203$17,56123 claims
AbbVieSynthroid$1,963$2,61531 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Lebanon

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →